Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNH2 | Q12809 | 2/20 | 0.43 |
| ▸ | ESPL1 | Q14674 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | CYP19A1 | P11511 | 4/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL231178 | 0.89 | KDM4E (0.42) | ESPL1MAPTALDH1A1TDP1CYP1A2 | |
| SCHEMBL458041 | 0.82 | POLB (0.43) | MAPTALDH1A1TDP1CYP1A2 | |
| SCHEMBL8182516 | 0.79 | KMT2A (0.38) | MAPTALDH1A1TDP1CYP1A2 | |
| SCHEMBL27773763 | 0.79 | TSHR (0.39) | KCNH2ALDH1A1TDP1CYP1A2 | |
| SCHEMBL5742336 | 0.78 | HTT (0.38) | MAPTALDH1A1TDP1CYP1A2 | |
| SCHEMBL11286333 | 0.78 | TSHR (0.45) | ALDH1A1TDP1CYP1A2CYP19A1 | |
| SCHEMBL9625596 | 0.77 | ALDH1A1 (0.37) | KCNH2ALDH1A1TDP1CYP1A2CYP19A1 | |
| SCHEMBL6377117 | 0.75 | TSHR (0.49) | MAPTALDH1A1TDP1CYP1A2 | |
| SCHEMBL7304803 | 0.75 | TSHR (0.42) | ALDH1A1TDP1CYP1A2 | |
| SCHEMBL5585098 | 0.75 | LOXL2 (0.46) | MAPTALDH1A1TDP1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2332940-B1 | Azaindoles useful as inhibitors of JAK and other protein kinases | VERTEX PHARMA (US) | 2012-10-31 | — | — | EP | claimed |
| EP-0699676-B1 | Physical form of dihidro-2,3-benzodiazepine derivative | LILLY CO ELI (US) | 2001-02-07 | — | — | EP | claimed |